Entero Therapeutics (ENTO) Files for 12M Share and Warrant Offering

Entero Therapeutics (NASDAQ: ENTO) has filed to offer the following:

We are offering 12,000,000 shares of our common stock, par value $0.0001 per share. We estimate that the public offering price will be $0.50 per share, based on the sale price of our common stock on The Nasdaq Capital Market, or Nasdaq, on June 16, 2025.

We are also offering pre-funded warrants (the “Pre-funded Warrants”) to purchase 12,000,000 shares of our common stock to those purchasers whose purchase of shares of common stock in this offering would result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of the issued and outstanding shares of our common stock immediately following the consummation of this offering, in lieu of shares of common stock. Each Pre-funded Warrant is exercisable for one share of our common stock at an exercise price of $0.0001 per share. For each Pre-funded Warrant that we sell, the number of shares of common stock we are offering will be reduced on a one-for-one basis.

You May Also Be Interested In

• Quantum Corporation (QMCO) files for 13.81M share offering by selling stockholders
• BP cuts Q2 2026 production outlook, net debt expected to fall
• Evercore ISI Starts SpaceX (SPCX) at Outperform